Insider · CIK 0001796226
Andrew J Murphy
officer
Files at REGN (REGENERON PHARMACEUTICALS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -1,054 | $730.81 | $770k | 49,074 | Dec 18, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock | +3,499 | $0.00 | $0 | 50,620 | Dec 10, 2024 |
| Dec 9, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -492 | $787.00 | $387k | 50,128 | Dec 10, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +13,472 | $0.00 | $0 | 13,472 | Dec 10, 2024 |
| Nov 8, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | GGift Common Stock | -1,185 | $0.00 | $0 | 47,121 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.